CORPORATE OVERVIEW
Company
The core business of Alphial S.r.l. is the transformation of hydrolytic class type 1 tubular glass into ampoules and vials for the pharmaceutical, chemical and cosmetic industries.
Thanks to continuous development and recent considerable investments, the company can now produce also sterile and apyrogenic ampoules, commonly called Ready to Use.
Inspection systems
Our constantly updated inspection systems ensure the top quality of our ampoules and vials. These processes are the cornerstone guaranteeing to our customers sustained quality and high degree of product reliability.
Certificates
These certifications are the assurance that we follow all the rules about manufacturing, systems, and management.
Primary packaging
Alphial S.r.l. is leader in the production of glass primary packaging for pharmaceutical, chemical and cosmetic use.
Production of glass ampoules and vials is mainly dedicated to contain
injectable medications and biotechnological solutions, as well as niche cosmetic treatments.
Research & Development
Alphial S.r.l. competitive advantage and name recognition is rooted in the quality of the products, the continuous commitment to research and development, the constantly expanding production capacity and its strong presence on all the international markets.
LS5
LS5 is the result of years of research and in-depth study. It is an innovative project that stands out compared to other sterile and ready to use packaging products currently available on the market.
PRODUCTION LINES
STERILE LINES
LS5
Sterile and Pyrogen Free
LS5 is the result of years of research and in-depth study. It is an innovative project that stands out compared to other sterile and ready to use packaging products currently available on the market. Our RTU vials are sterile, apyrogenic and they are not sterilized through external treatments but exclusively through traditional pharmaceutical process. The control systems we apply are among the most advanced on the market. The top quality of the products and the particularly long shelf life of the sterile ampoules are a remarkable achievement.
NEWS
CPHI 2024 di Milano
We are thrilled to announce that we will be exhibiting at the CPHI 2024 in Milan.
Pharmap Congress 2024 in Amsterdam
We are thrilled to announce that we will be exhibiting at the Pharmap Congress 2024 in Amsterdam.
New acquisitions
The acquisition is part of the company’s strategic plan, which has set itself the goal of making important industrial investments, strengthening production capacity and building a customer/product portfolio of extremely high value.
